Introduction

Company name: Merial Animal Health Ltd

Address: PO Box 327

Sandringham House

Harlow Business Park

Harlow

Essex CM19 5TG

Telephone: 01279 775858

Fax: 01279 775888

Email: ukenquiry@merial.com

Website: www.merial.com

Presentation

A live attenuated canine parvovirus vaccine presented as a buff coloured freeze-dried pellet.

Uses

For the active immunisation of dogs from 8 weeks of age to prevent mortality and clinical signs and to reduce viral excretion caused by canine parvovirus infection.

Onset of immunity: 7 days after primary vaccination.

Duration of immunity: 1 year after primary vaccination and 2 years after boosters.

Dosage and administration

Reconstitute EURICAN P using EURICAN L immediately before use. Apply usual aseptic procedures and inject by the subcutaneous route.

It is well documented that high levels of maternally derived antibodies can interfere with an active immune response to vaccination. Ideally pups should be vaccinated as soon as maternally derived antibody has declined to a level at which the pup is susceptible. Under most practical circumstances this is not known and therefore the following regime is recommended.

For dogs and puppies from 8 weeks of age inject a 1 ml dose according to the following schedule:

Basic vaccination:

Puppies less than 12 weeks old:

First vaccination: from 8 weeks of age

Second vaccination: 3 to 5 weeks later from 12 weeks of age.

In puppies over 12 weeks of age a single injection is sufficient to confer immunity.

Re-vaccination:

One injection of EURICAN P one year after the primary vaccination followed by a booster injection every two years.

Contra-indications, warnings, etc

For animal treatment only.

Do not vaccinate sick animals.

In rare cases, slight and transient pain may be apparent at the time of injection, which regresses within 2 hours. In exceptional circumstances a hypersensitivity reaction may occur which may require appropriate symptomatic treatment.

In the absence of data from studies in seronegative bitches, EURICAN P should only be used in pregnant bitches which have previously been vaccinated before pregnancy.

No information is available on the safety and efficacy from the concurrent use of this vaccine with any other except EURICAN L. It is therefore recommended that no other vaccines should be administered within 14 days before or after vaccination with EURICAN P.

Do not mix with any other medicinal product except EURICAN L.

Pharmaceutical precautions

Store and transport at +2°C to +8°C protected from light. Do not freeze.

Use immediately after reconstitution.

Keep out of reach of children.

Dispose of waste material by boiling, incineration or immersion in an appropriate disinfectant approved for use by the competent authorities.

Legal category

POM-V

Packaging Quantities

Packs containing 10 single dose vials.

Further information

As may be expected for a live canine parvovirus vaccine, EURICAN P is shed from vaccinates and can be transmitted to in-contact dogs. However, due to the absence of pathogenicity of the strain, this should have no adverse effect on the in-contact dog.

Following the administration of overdoses of vaccine, slight and transient pain and oedema appear which regresses within 1 day.

Marketing authorisation number

Vm 08327/4151.